Summary: Earable Neuroscience’s FRENZ Brainband has secured its third consecutive CES Innovation Award, recognized in the Digital Health category for its Focus Flow mobile app. The wearable leverages real-time brainwave tracking and personalized audio therapy to improve cognitive performance and mental wellness. At CES 2025, the company launched the Focus Flow app, introduced the FRENZ Brainwaves Labs platform for B2B partnerships, and highlighted its advancements in neurotechnology through collaborations and panel discussions.
Key Takeaways:
- Recognition for Innovation: FRENZ Brainband has earned its third CES Innovation Award, showcasing its ability to combine sleep tracking, focus enhancement, and neurofeedback in a wearable platform.
- New App for Focus Enhancement: The Focus Flow app, launched at CES 2025, uses brainwave tracking and specialized audio therapy to improve concentration and cognitive performance during demanding tasks.
- B2B Partnerships for Cognitive Health: The newly introduced FRENZ Brainwaves Labs invites collaborations with universities, pharmaceutical companies, and corporate wellness programs to advance research in brainwave monitoring and sleep tracking as biomarkers for mental health.
Earable Neuroscience has been honored by the Consumer Technology Association (CTA) with its third consecutive CES Innovation Awards for FRENZ Brainband’s personalized audio therapy platform that uses real-time brainwave tracking to enhance sleep and focus.
The CTA is the organization behind the Consumer Electronics Show (CES). FRENZ Brainband has earned CES Innovation Awards across three categories:
- Wearable Tech (2023): FRENZ Brainband – an AI-powered sleep wearable with CBT-I therapy solutions.
- Accessibility and Aging Tech (2024): FRENZ Sleep Science Mobile App, clinically proven efficacy and its impact on the longevity industry.
- Digital Health (2025): FRENZ Focus Flow Mobile App, a consumer wearable to track and enhance focus through personalized audio therapy.
“Achieving this CES hat trick is a significant milestone,” says Tam Vu, founder of Earable Neuroscience, in a release. “It demonstrates the evolution of FRENZ into a multi-functional, AI-powered EEG-based platform for enhancing sleep, focus, and cognitive performance for daily application.”
With 35 patents and patent-pending technologies and multiple Best Paper Awards in wearable and AI-based sensory tech, Vu has also been appointed to the jury board for CES Innovation Awards 2025 AI category. Additionally, Earable’s chief innovation officer, Kimi Doan, will join a panel discussion on neurotechnology at CES on Jan 7. During the session, “Everyday Neurotech: Brain-Computer Interfaces for All,” Doan will share how FRENZ integrates neuroscience into practical, everyday applications to enhance mental health and productivity.
Unveiling Focus Flow
At CES 2025, Earable introduced the Focus Flow mobile app, which builds on the clinically validated FRENZ Brainband. Focus Flow delivers personalized neurofeedback using real-time brainwave tracking to train the brain for improved concentration during demanding tasks. The science-backed therapy uses specialized frequency music, binaural beats, and contextual audio cues, designed to increase beta and gamma activity in the brain’s frontal lobe.
“Focus Flow has been in development by our in-house lab team and industry partners for over two years, involving more than 10,000 training sessions and millions of focus epoch samples,” says Vu in a release. “With our R&D roadmap, this feature not only delivers a cognitive boost but also advances our understanding of brainwaves as biomarkers for mental health and cognitive performance.”
Global Call for B2B Partnerships
Earable Neuroscience launched at CES 2025 the FRENZ Brainwaves Labs, a platform designed to foster collaborations with universities, pharmaceutical companies, and corporate wellness programs. Partners gain access to advanced APIs, raw data, and the opportunity to co-develop cutting-edge algorithms tailored to their unique needs.
“FRENZ Brainwaves Labs connects scientific innovation with practical applications,” says Doan in a release. “By harnessing advanced brainwave monitoring and sleep tracking as biomarkers, we aim to unlock new possibilities in cognitive health. Research areas currently include neurodegenerative disease discovery, epilepsy monitoring, stroke rehabilitation, pain management, and neuroplasticity.”
The FRENZ Brainband for B2B offers research-grade real-time access to biomarkers, including brainwaves, heart rate, SpO2, facial muscle activity, and eye movement.
FRENZ Brainwaves Labs is partnering with MedM, a leader in remote patient monitoring. MedM is known for its sensor-agnostic compatibility and seamless integration with healthcare systems, along with its consumer app, which has over 500,000 users worldwide. This collaboration is set for a Q2 2025 launch.
Earable Neuroscience invites academic institutions, pharmaceutical companies, healthcare innovators, and corporate wellness leaders to collaborate.
The CES Innovation Awards are based upon descriptive materials submitted to the judges. CTA did not verify the accuracy of any submission or of any claims made and did not test the item to which the award was given.
Photo caption: FRENZ brainband
Photo credit: Earable Neuroscience
